购物车
- 全部删除
- 您的购物车当前为空
ICCB280 是一种 C/EBPα诱导剂,通过激活 C/EBPα 并影响其下游靶点,具有终末分化、增殖停滞和凋亡的抗白血病特性。
为众多的药物研发团队赋能,
让新药发现更简单!
ICCB280 是一种 C/EBPα诱导剂,通过激活 C/EBPα 并影响其下游靶点,具有终末分化、增殖停滞和凋亡的抗白血病特性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 738 | 现货 | |
2 mg | ¥ 1,080 | 现货 | |
5 mg | ¥ 1,820 | 现货 | |
10 mg | ¥ 3,230 | 现货 | |
25 mg | ¥ 5,230 | 现货 | |
50 mg | ¥ 7,470 | 现货 | |
100 mg | ¥ 9,860 | 现货 | |
500 mg | ¥ 19,700 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,870 | 现货 |
产品描述 | ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis. |
靶点活性 | Others:8.6 μM |
体外活性 | ICCB280 (10 μM; 2-8 d) increases the C/EBPα expression (mRNA and protein) and modulates its target genes in HL-60 cells.ICCB280 (0.1-50 μM; 48 h) suppresses the HL-60 cell growth, with an IC50 of 8.6 μM[1]. |
分子量 | 386.4 |
分子式 | C23H18N2O4 |
CAS No. | 2041072-41-5 |
Smiles | COc1ccccc1-n1c(\C=C\c2ccc(O)c(O)c2)nc2ccccc2c1=O |
密度 | 1.28 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (142.34 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容